Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis. Issue 203 (July 2021)

• Record Type: Journal Article
• Authors: Moll, Matthew; Zon, Rebecca L.; Sylvester, Katelyn W.; Rimsans, Jessica; Chen, Evan C.; Ghosh, Auyon J.; Abston, Eric; Kim, Andy; Rutherford, Henry; Mitre, Xhoi; Hakim, Aaron; Connell, Nathan T.; Battinelli, Elisabeth; Fredenburgh, Laura E.; Baron, Rebecca M.; Hobbs, Brian D.; Cho, Michael H.; Mittleman, Murray A.; Woolley, Ann E.; Connors, Jean M.
• Is Part Of: Thrombosis research. Issue 203(2021)
• Page Start: 57
• Page End: 60
• Publication Date: 2021-07
• Subjects: ACTIV accelerating COVID-10 therapeutic interventions and vaccines -- ANOVA analysis of variance -- BiPAP bilevel positive airway pressure -- BWH Brigham and Women's Hospital -- BWFH Brigham and Women's Faulkner Hospital -- CI confidence interval -- COVID-19 clinical syndrome for infection with SARS-CoV-2 -- CVVH continuous veno-venous hemofiltration -- DVT deep venous thrombosis -- HFNC high-flow nasal cannula -- ICU intensive care unit -- INSPIRATION Intermediate versus Standard-dose Prophylactic anticoagulation In cRitically-ill pATIents with COVID-19: An opeN label randomized controlled trial -- IRB Institutional Review Board -- ISTH International Society on Thrombosis and Haemostasis -- IU International units -- KM Kaplan-Meier -- mg milligrams -- kg kilograms -- RRS-SARS-CoV-2 Research Registry for the Study of SARS-CoV-2 Infection -- SARS-CoV2 severe acute respiratory syndrome - coronavirus-2 -- VTE venous thromboembolism; COVID-19 -- Critical care -- Intermediate dose -- Heparin -- Anticoagulation; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2021.04.009
• Languages: English
• ISSNs: 0049-3848